https://vaccinedatanavigator.org/vaccine-pipeline.htmlVaccine candidates by most recent registry or regulatory status date (ClinicalTrials.gov and regulators). Registry dates may lag company announcements. Not medical advice.enSat, 01 Aug 2026 00:00:00 +0000https://vaccinedatanavigator.org/pipeline/mrna-1083.htmlmrna-1083|2026-08-01|regulatory_submission_filedSat, 01 Aug 2026 00:00:00 +0000mRNA-1083 (Moderna Combined Influenza + COVID-19 mRNA Vaccine) from Moderna for Seasonal influenza + COVID-19 (combination); current stage Submitted to regulators. FDA target PDUFA action date and ACIP review for 2025-2026 respiratory season Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ixchiq.htmlixchiq|2026-08-01|approvedSat, 01 Aug 2026 00:00:00 +0000Ixchiq (VLA1553 / Chikungunya live-attenuated vaccine) from Valneva for Chikungunya; current stage Approved. Post-marketing safety surveillance; adolescent trial data readout Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-ixchiq.htmlfda-ixchiq|2026-08-01|approvedSat, 01 Aug 2026 00:00:00 +0000Ixchiq (VLA1553 / Chikungunya live-attenuated vaccine) from Valneva Austria GmbH for Chikungunya; current stage Approved. Post-marketing safety surveillance; adolescent trial data readout Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-vla1553-valneva-austria-gmbh.htmlctgov-vla1553-valneva-austria-gmbh|2026-08-01|approvedSat, 01 Aug 2026 00:00:00 +0000Ixchiq (VLA1553 / Chikungunya live-attenuated vaccine) from Valneva Austria GmbH for Chikungunya; current stage Approved. Post-marketing safety surveillance; adolescent trial data readout Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-mrna-1345-modernatx-inc.htmlctgov-mrna-1345-modernatx-inc|2026-08-01|approvedSat, 01 Aug 2026 00:00:00 +0000mRESVIA (mRNA-1345 / RSV vaccine) from ModernaTX, Inc. for RSV; current stage Approved. Global commercial distribution; expanded adult age-group trials Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/vla15.htmlvla15|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000VLA15 from Valneva / Pfizer for Lyme disease; current stage Phase 3. VALOR Phase 3 field efficacy results (company: H1 2026); BLA/MAA planned if positive Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/vax-31-adult.htmlvax-31-adult|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000VAX-31 (adult) from Vaxcyte for Invasive pneumococcal disease (31-valent conjugate); current stage Phase 3. Topline data from OPUS-1 (company: Q4 2026); planned BLA submission to follow if positive Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/pfizer-dual-flu-covid.htmlpfizer-dual-flu-covid|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Influenza + COVID combination candidates (Pfizer/BioNTech family) from Pfizer / BioNTech for Seasonal influenza + COVID-19 (combination); current stage Phase 3. Phase 3 readouts and potential regulatory filings (company-dependent; verify latest 10-Q/investor materials) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/novavax-flu-covid.htmlnovavax-flu-covid|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000COVID-Influenza Combination (CIC) — Novavax from Novavax for Seasonal influenza + COVID-19 (combination); current stage Phase 3. Phase 3 data and potential regulatory path (company projection — verify latest filings) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/mrna-1345-rsv.htmlmrna-1345-rsv|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000mRNA-1345 (mRESVIA context / next-gen RSV programs) from Moderna for RSV; current stage Approved. Label expansions / seasonal updates as disclosed; see licensed RSV page for post-licensure safety Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/mrna-1010.htmlmrna-1010|2026-07-10|regulatory_submission_filedFri, 10 Jul 2026 00:00:00 +0000mRNA-1010 from Moderna for Seasonal influenza; current stage Submitted to regulators. Regulatory decision(s) pending across filed jurisdictions (company projection) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-zoster-vaccine-recombinant-adjuvanted.htmlfda-zoster-vaccine-recombinant-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Zoster Vaccine Recombinant, Adjuvanted from See FDA listing for Varicella / Zoster; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-vimkunya.htmlfda-vimkunya|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000VIMKUNYA from See FDA listing for Chikungunya; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-vaxelis.htmlfda-vaxelis|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000VAXELIS from MCM Vaccine Company for Diphtheria / Tetanus / Pertussis / Polio / Hib / HepB; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-spikevax.htmlfda-spikevax|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000SPIKEVAX from ModernaTX, Inc. for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-smallpox-and-monkeypox-vaccine-live-non-replicating.htmlfda-smallpox-and-monkeypox-vaccine-live-non-replicating|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Smallpox and Monkeypox Vaccine, Live, Non-Replicating from See FDA listing for Mpox / Smallpox; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-respiratory-syncytial-virus-vaccine-adjuvanted.htmlfda-respiratory-syncytial-virus-vaccine-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Respiratory Syncytial Virus Vaccine, Adjuvanted from See FDA listing for RSV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-respiratory-syncytial-virus-vaccine.htmlfda-respiratory-syncytial-virus-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Respiratory Syncytial Virus Vaccine from See FDA listing for RSV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-priorix.htmlfda-priorix|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000PRIORIX from GlaxoSmithKline Biologicals for Measles / Mumps / Rubella; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-pneumococcal-21-valent-conjugate-vaccine.htmlfda-pneumococcal-21-valent-conjugate-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Pneumococcal 21-valent Conjugate Vaccine from See FDA listing for Pneumococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-pneumococcal-20-valent-conjugate-vaccine.htmlfda-pneumococcal-20-valent-conjugate-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Pneumococcal 20-valent Conjugate Vaccine from See FDA listing for Pneumococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-pneumococcal-15-valent-conjugate-vaccine.htmlfda-pneumococcal-15-valent-conjugate-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Pneumococcal 15-valent Conjugate Vaccine from See FDA listing for Pneumococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-penmenvy.htmlfda-penmenvy|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000PENMENVY from See FDA listing for Meningococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-penbraya.htmlfda-penbraya|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000PENBRAYA from See FDA listing for Meningococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-nuvaxovid.htmlfda-nuvaxovid|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000NUVAXOVID from Novavax, Inc. for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-mresvia.htmlfda-mresvia|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000mRESVIA from ModernaTX, Inc. for RSV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-mnexspike.htmlfda-mnexspike|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000MNEXSPIKE from See FDA listing for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-meningococcal-groups-a-b-c-w-and-y-vaccine.htmlfda-meningococcal-groups-a-b-c-w-and-y-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Meningococcal Groups A, B, C, W, and Y Vaccine from See FDA listing for Meningococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-meningococcal-group-b-vaccine.htmlfda-meningococcal-group-b-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Meningococcal Group B Vaccine from See FDA listing for Meningococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-measles-mumps-and-rubella-vaccine-live.htmlfda-measles-mumps-and-rubella-vaccine-live|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Measles, Mumps and Rubella Vaccine, Live from See FDA listing for Measles / Mumps / Rubella; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-virus-vaccine-trivalent-types-a-and-b.htmlfda-influenza-virus-vaccine-trivalent-types-a-and-b|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza Virus Vaccine(Trivalent, Types A and B) from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-vaccine-trivalent.htmlfda-influenza-vaccine-trivalent|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza Vaccine (Trivalent) from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-vaccine-quadrivalent.htmlfda-influenza-vaccine-quadrivalent|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza Vaccine (Quadrivalent) from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-vaccine-adjuvanted.htmlfda-influenza-vaccine-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza Vaccine, Adjuvanted from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-vaccine.htmlfda-influenza-vaccine|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza Vaccine from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-influenza-a-h5n1-monovalent-vaccine-adjuvanted.htmlfda-influenza-a-h5n1-monovalent-vaccine-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Influenza A (H5N1) Monovalent Vaccine, Adjuvanted from See FDA listing for Influenza; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-human-papillomavirus-9-valent-vaccine-recombinant.htmlfda-human-papillomavirus-9-valent-vaccine-recombinant|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Human Papillomavirus 9-valent Vaccine, Recombinant from See FDA listing for HPV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-hepatitis-b-vaccine-recombinant-adjuvanted.htmlfda-hepatitis-b-vaccine-recombinant-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Hepatitis B Vaccine (Recombinant), Adjuvanted from See FDA listing for Hepatitis B; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-hepatitis-b-vaccine-recombinant.htmlfda-hepatitis-b-vaccine-recombinant|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Hepatitis B Vaccine (Recombinant) from See FDA listing for Hepatitis B; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-ebola-zaire-vaccine-live.htmlfda-ebola-zaire-vaccine-live|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Ebola Zaire Vaccine, Live from See FDA listing for Ebola; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-diphtheria-and-tetanus-toxoids-and-acellular-pertussis-a.htmlfda-diphtheria-and-tetanus-toxoids-and-acellular-pertussis-a|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Mening from See FDA listing for Meningococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-dengue-tetravalent-vaccine-live.htmlfda-dengue-tetravalent-vaccine-live|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Dengue Tetravalent Vaccine, Live from See FDA listing for Dengue; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-cyfendus.htmlfda-cyfendus|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000CYFENDUS from Emergent BioSolutions for Anthrax; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-covid-19-vaccine-mrna.htmlfda-covid-19-vaccine-mrna|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000COVID-19 Vaccine, mRNA from See FDA listing for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-covid-19-vaccine-adjuvanted.htmlfda-covid-19-vaccine-adjuvanted|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000COVID-19 Vaccine, Adjuvanted from See FDA listing for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-comirnaty.htmlfda-comirnaty|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000COMIRNATY from Pfizer-BioNTech for COVID-19; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-chikungunya-vaccine-recombinant.htmlfda-chikungunya-vaccine-recombinant|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000Chikungunya Vaccine, Recombinant from See FDA listing for Chikungunya; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-capvaxive.htmlfda-capvaxive|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000CAPVAXIVE from See FDA listing for Pneumococcal disease; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-arexvy.htmlfda-arexvy|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000AREXVY from GlaxoSmithKline Biologicals for RSV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/fda-abrysvo.htmlfda-abrysvo|2026-07-10|approvedFri, 10 Jul 2026 00:00:00 +0000ABRYSVO from Pfizer Inc. for RSV; current stage Approved. US-licensed — see product label / ACIP for use; further supplements may expand indication Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-zigakibart-novartis-pharmaceuticals.htmlctgov-zigakibart-novartis-pharmaceuticals|2026-07-10|phase_2Fri, 10 Jul 2026 00:00:00 +0000zigakibart from Novartis Pharmaceuticals for Immunoglobulin A Nephropathy (IgAN); current stage Phase 2. Primary completion (most advanced trial): 2030-07-12 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-z-1018-dynavax-technologies-corporation.htmlctgov-z-1018-dynavax-technologies-corporation|2026-07-10|phase_2Fri, 10 Jul 2026 00:00:00 +0000Z-1018 from Dynavax Technologies Corporation for Varicella / Zoster; current stage Phase 2. Primary completion (most advanced trial): 2027-11 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-yellow-fever-vaccine-produced-on-serum-free-vero-cells-sanofi-pa.htmlctgov-yellow-fever-vaccine-produced-on-serum-free-vero-cells-sanofi-pa|2026-07-10|phase_2Fri, 10 Jul 2026 00:00:00 +0000Yellow fever vaccine from Sanofi Pasteur, a Sanofi Company for Yellow fever; current stage Phase 2. Primary completion (most advanced trial): 2022-06-24 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-yellow-fever-vaccine-live-sanofi.htmlctgov-yellow-fever-vaccine-live-sanofi|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Yellow fever vaccine (live) from Sanofi for Yellow fever; current stage Phase 3. Primary completion (most advanced trial): 2026-08-08 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-yellow-fever-vaccination-17-dd-biomanguinhos-oswaldo-cruz-founda.htmlctgov-yellow-fever-vaccination-17-dd-biomanguinhos-oswaldo-cruz-founda|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Yellow Fever vaccination (17 DD Biomanguinhos) from Oswaldo Cruz Foundation for Yellow fever; current stage Phase 3. Primary completion (most advanced trial): 2018-12 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-walvax-pcv13-tt-walvax-biotechnology-co-ltd.htmlctgov-walvax-pcv13-tt-walvax-biotechnology-co-ltd|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Pfizer PCV13 from Walvax Biotechnology Co., Ltd. for Pneumococcal disease; current stage Phase 3. Primary completion (most advanced trial): 2025-03 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-vxb-241-60-mcg-low-dose-sanofi.htmlctgov-vxb-241-60-mcg-low-dose-sanofi|2026-07-10|phase_1Fri, 10 Jul 2026 00:00:00 +0000VXB-241 240 mcg from Sanofi for RSV; current stage Phase 1. Primary completion (most advanced trial): 2025-02-14 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-vaxigrip-tetra-sanofi-pasteur-europe-aarhus-university-hospital.htmlctgov-vaxigrip-tetra-sanofi-pasteur-europe-aarhus-university-hospital|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Vaxigrip Tetra Sanofi Pasteur Europe from Aarhus University Hospital for Influenza; current stage Phase 3. Primary completion (most advanced trial): 2026-05-01 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-vaicella-vaccine-dtap-on-day-0-mmr-on-day-30-sinovac-dalian-vacc.htmlctgov-vaicella-vaccine-dtap-on-day-0-mmr-on-day-30-sinovac-dalian-vacc|2026-07-10|phase_3Fri, 10 Jul 2026 00:00:00 +0000Varicella Vaccine from Sinovac (Dalian) Vaccine Technology Co., Ltd. for Measles / Mumps / Rubella; current stage Phase 3. Primary completion (most advanced trial): 2025-12 (registry estimate) Registry dates may lag company announcements.https://vaccinedatanavigator.org/pipeline/ctgov-vaccine-candidate-1-pfizer.htmlctgov-vaccine-candidate-1-pfizer|2026-07-10|phase_2Fri, 10 Jul 2026 00:00:00 +0000Pfizer mRNA influenza vaccine candidates (#1-#6, unnamed) from Pfizer for Influenza; current stage Phase 2. Primary completion (most advanced trial): 2027-06-22 (registry estimate) Registry dates may lag company announcements.